<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05620745</url>
  </required_header>
  <id_info>
    <org_study_id>CMRPG3M1351</org_study_id>
    <nct_id>NCT05620745</nct_id>
  </id_info>
  <brief_title>Comparison of Resilience Between ADHD and Controls.</brief_title>
  <official_title>Resilience as a Mediator Between Adverse Life Events and Emotional Behavioral Problems in Children and Adolescents and Comparison Between Individuals With Attention-Deficit /Hyperactive Disorder and Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore if resilience serves as a mediator between adverse life events and emotional and&#xD;
      behavioral problems, and compare the difference of resilience and its mediating effects&#xD;
      between children and adolescents with and without ADHD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of resilience between ADHD and controls</measure>
    <time_frame>up to 1 month</time_frame>
    <description>We will use SPSS and SPSS PROCESS to analyze the data. The t-test will be used to compare the difference of resilience performance between child and adolescents with and without ADHD.&#xD;
Pearson correlation analyses will be adopted to calculate the relationships between all variables.&#xD;
Moreover, the bias-corrected method was used to estimate the 95% bootstrap confidence interval (CI)of the mediating and moderating effects of resilience between adverse life events and emotional and behavioral problems. Finally, we would compare if there is difference between the mediating effect of resilience in group with ADHD and control group.</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>ADHD; Resilience; Stress</condition>
  <eligibility>
    <study_pop>
      <textblock>
        cases ever diagnosed as ADHD; Controls who didn't recieve ADHD diganosis before.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ADHD; Control without ADHD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASD, other major physical and psychiatric diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Hsiang Lin Chan, MD</last_name>
    <phone>886 033281200</phone>
    <phone_ext>3824</phone_ext>
    <email>8802038@adm.cgmh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chang Gung memorial hospital</name>
      <address>
        <city>Taoyuan city</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hsiang Lin Chan, MD</last_name>
      <phone>+886 033281200</phone>
      <phone_ext>3824</phone_ext>
      <email>ivyhlin70@kimo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 26, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>November 9, 2022</last_update_submitted>
  <last_update_submitted_qc>November 9, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

